Cargando…

Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV

BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Galileu Barbosa, Augusto, Lídia Teodoro Santos, Leite, Juliana Almeida, Ferreira, Paulo César Peregrino, Bonjardim, Cláudio Antônio, Abrahão, Jônatas Santos, Kroon, Erna Geessien, Moreno, Elizabeth Castro, Trindade, Giliane de Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932698/
https://www.ncbi.nlm.nih.gov/pubmed/27377374
http://dx.doi.org/10.1186/s12985-016-0575-6
_version_ 1782441110463840256
author Costa, Galileu Barbosa
Augusto, Lídia Teodoro Santos
Leite, Juliana Almeida
Ferreira, Paulo César Peregrino
Bonjardim, Cláudio Antônio
Abrahão, Jônatas Santos
Kroon, Erna Geessien
Moreno, Elizabeth Castro
Trindade, Giliane de Souza
author_facet Costa, Galileu Barbosa
Augusto, Lídia Teodoro Santos
Leite, Juliana Almeida
Ferreira, Paulo César Peregrino
Bonjardim, Cláudio Antônio
Abrahão, Jônatas Santos
Kroon, Erna Geessien
Moreno, Elizabeth Castro
Trindade, Giliane de Souza
author_sort Costa, Galileu Barbosa
collection PubMed
description BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. METHODS: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. RESULTS: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies. CONCLUSIONS: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection.
format Online
Article
Text
id pubmed-4932698
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49326982016-07-06 Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV Costa, Galileu Barbosa Augusto, Lídia Teodoro Santos Leite, Juliana Almeida Ferreira, Paulo César Peregrino Bonjardim, Cláudio Antônio Abrahão, Jônatas Santos Kroon, Erna Geessien Moreno, Elizabeth Castro Trindade, Giliane de Souza Virol J Research BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. METHODS: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. RESULTS: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies. CONCLUSIONS: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection. BioMed Central 2016-07-04 /pmc/articles/PMC4932698/ /pubmed/27377374 http://dx.doi.org/10.1186/s12985-016-0575-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Costa, Galileu Barbosa
Augusto, Lídia Teodoro Santos
Leite, Juliana Almeida
Ferreira, Paulo César Peregrino
Bonjardim, Cláudio Antônio
Abrahão, Jônatas Santos
Kroon, Erna Geessien
Moreno, Elizabeth Castro
Trindade, Giliane de Souza
Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title_full Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title_fullStr Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title_full_unstemmed Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title_short Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
title_sort seroprevalence of orthopoxvirus in rural brazil: insights into anti-opv immunity status and its implications for emergent zoonotic opv
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932698/
https://www.ncbi.nlm.nih.gov/pubmed/27377374
http://dx.doi.org/10.1186/s12985-016-0575-6
work_keys_str_mv AT costagalileubarbosa seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT augustolidiateodorosantos seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT leitejulianaalmeida seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT ferreirapaulocesarperegrino seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT bonjardimclaudioantonio seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT abrahaojonatassantos seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT kroonernageessien seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT morenoelizabethcastro seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv
AT trindadegilianedesouza seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv